ILCA is very pleased to announce that the next edition of the ILCA School of Liver Cancer, Aarhus, Denmark, will be virtual this May 2021.
The ILCA School will assemble multi-disciplinary experts on hepatocellular carcinoma and cholangiocarcinoma from Aarhus University Hospital, University of Copenhagen and specialists, exclusively invited from Scandinavia, the USA, Spain and France.
The event will to provide a summary of the current state-of-the- art knowledge of the pathogenesis and clinical management of hepatocellular carcinoma and the research conducted internationally. In addition, the participants will be exposed to the clinical management of HCC and cholangiocarcinoma and critical sessions discussing clinical trials.
Sign today to get the deepest knowledge on:
- Recent developments in the genomics of liver cancer and their therapeutic implications.
- Current indications for resection and transplantation vis-a-vis medical and non-surgical locoregional modalities.
- The systemic current management of HCC and intrahepatic cholangiocarcinoma and the opportunities of improvement in the near future.
Programme
Friday 7 May | |
08:30 – 08:45 | Introduction to the ILCA School of Liver Cancer Gerda Elisabeth Villadsen, MD, PhD, Ass. Professor, Aarhus University Hospital, DenmarkWelcome note Chief Medical Officer Jørgen Schøler Kristensen, Aarhus University Hospital, Denmark |
08:45 – 09:00 | Interactive quiz – session warm up Henning Grønbæk, MD, PhD, Professor & Consultant, Aarhus University Hospital, Denmark |
OVERVIEW OF MANAGEMENT OF HCC (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Frank Viborg Mortensen, MD, DMSc, Professor, HBP surgery, Aarhus University Hospital, Denmark) |
|
09:00 – 09:20 | Epidemiology and Surveillance for HCC Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark |
09:20 – 09:35 | Fast Track and Multidisciplinary Approach to HCC Gerda Elisabeth Villadsen MD, PhD, Aarhus University Hospital, Denmark |
09:35 – 09:45 | Discussion |
09:45 – 10:00 | Virtual Coffee Break |
PATHOLOGY, ONCOGENOMICS, CIRCULATING TUMOR DNA AND TUMOR CELLS (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Britta Weber, MD, PhD, Aarhus University Hospital, Denmark) |
|
10:00- 10:20 | Biopsy Diagnosis and Pathology Profiling Stephen J. Hamilton Dutoit, MD, Professor, Aarhus University Hospital, Denmark |
10:20 – 10:50 | Oncogenomics in HCC and Cholangiocarcinoma Jesper Bøje Andersen, MSc, PhD University of Copenhagen, Denmark |
10:55 – 11:15 | Circulating Tumor DNA and Tumor Cells in HCC Jens Kelsen, MD, PhD, Aarhus University Hospital, Denmark |
11:15 – 11:35 | Discussion |
11:35 – 11:50 | Virtual Coffee Break |
IMAGING OF HCC (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Morten Høyer, MD, PhD, Professor, Aarhus University Hospital, Denmark) |
|
11:50 – 12:15 | The role of imaging (US, CT, MRI) in HCC Lars Peter Larsen, MD, PhD, Aarhus University Hospital, Denmark |
12:25 – 12:45 | The role of Molecular Imaging in HCC Michael Sørensen, MD, PhD, Aarhus University Hospital, Denmark |
12:45 – 13:00 | Discussion |
13:00 – 13:45 | Virtual Lunch Break |
13:45 – 14:00 | Interactive quiz – session warm up Henning Grønbæk, MD, PhD, Professor & Consultant, Aarhus University Hospital, Denmark |
SURGERY IN HCC AND CHOLANGIOCARCINOMA (Chair: Nicolai Aagaard Schultz , MD PhD, Liver Surgery, Rigshospitalet , Copenhagen, Denmark & Kirsten Muri Boberg professor , Oslo University Hospital, Norway & Magnus Ritzell , Head of Liver Surgery, Gotenburg University Sweden) |
|
14:00 – 14:20 | Preoperative Evaluation of Liver Function Before Resection Niels Kristian Aagaard, MD, PhD, Aarhus University Hospital, Denmark |
14:20 – 14:40 | Resection of HCC in a Cirrhotic Liver Bård Røsok, MD, PhD, Oslo University Hospital, Norway |
14:40 – 15:10 | HCC, Surgery and Liver transplantation: Is it Time to Abandon the Milan Criteria? Myron Schwartz, MD, Professor, Mount Sinai Hospital, New York, US |
15:10 – 15:40 | Surgery and Transplantation for Cholangiocarcinoma Eric Vibert, MD, PhD, Professor, Université Paris Saclay, France |
15:40 – 16:10 | Discussion |
16:10 – 16:25 | Virtual Coffee Break |
INTRODUCTION TO SYSTEMIC THERAPY IN HCC (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Kirsten Vistisen, MD, PhD, Herlev University Hospital, University of Copenhagen, Denmark) |
|
16:25 – 17:00 | Advanced HCC Systemic Therapy – from Sorafenib to immunotherapy Richard Finn, MD, Professor, UCLA, California, US |
17:00 – 17:15 | Discussion |
Saturday 8 May | |
08:30 – 08:45 | Highlights From Day 1 Henning Grønbæk, MD, PhD, Professor & Consultant, Aarhus University Hospital, Denmark |
LOCOREGIONAL TREATMENT FOR HCC (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Gerda Elisabeth Villadsen MD, PhD, Aarhus University Hospital, Denmark) |
|
08:45 – 09:15 | The Role of Ablation and TACE for HCC Maria Reig, MD, DMSc, Professor, University of Barcelona, Spain |
09:15 – 09:45 | The Role of Radioembolisation in HCC Bruno Sangro, MD, PhD, Professor University of Navarra, Spain |
09:45 – 10:05 | Discussion |
10:05 – 10:20 | Virtual Coffee Break |
RADIOTHERAPY IN PRIMARY LIVER CANCER (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Hanna R. Mortensen, MD, PhD, Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark) |
|
10:20 – 10:40 | Stereotactic Body Radiotherapy for Liver Cancer Britta Weber, MD, PhD, Aarhus University Hospital, Denmark |
10:40 – 11:00 | Particle Therapy, a New Treatment for Liver Cancer Morten Høyer, MD, PhD, Professor, Aarhus University Hospital, Denmark |
SYSTEMIC TREATMENTS FOR HCC AND CHOLANGIOCARCINOMA (Chair: Peter Jepsen, MD, PhD, Aarhus University Hospital, Denmark & Britta Weber, MD, PhD, Aarhus University Hospital, Denmark) |
|
11:15 – 11:35 | Systemic Treatments in Cholangiocarcinoma Morten Ladekarl, DMSc, Professor, Aalborg University Hospital, Denmark |
11:35 – 11:55 | Benefits and Risks of Immunotherapy Inge Marie Svane, PhD, Professor, Herlev University Hospital, Denmark |
11:55 – 12:15 | Discussion |
12:15 – 12:35 | A patient perspective of living with HCC – what is important? Tora Dahl, Danish Liver Association |
12:35 – 12:45 | Q&A |
12:45 – 13:00 | Closing Remarks Gerda Elisabeth Villadsen MD, PhD, Ass. Professor, Aarhus University Hospital, Denmark |